Information for Publications and Grants

Acknowledgement of DHVI Shared Resource Facilities in publications is appreciated and helps to demonstrate our utility to Duke and funding sources.  The DHVI FacMan system will routinely request database updates from Principal Investigators regarding publications (PMCID #s) and grant funding that were supported by our facilities. 

 

Click here for examples of publication acknowledgement text for DHVI Shared Resource Facilities. 

 

DHVI Shared Resource Facilities are supported by a variety of shared instrumentation grants, center grants, and program awards.  Acknowledgement of applicable funding in publications is required and helps to demonstrate our utility to funding sponsors. 

 

Click here for affiliated funding acknowledgement text associated with your studies.

 

DHVI Shared Resource Facilities offer a wide-range of state-of-the-art Biocontainment facilities, instrumentation and services to support research initiatives in the areas of Vaccine Immunology, Immune Reconstitution, Host Pathogen Interaction, and Emerging Infectious Disease and Biodefense.  Our facility directors and financial management team can assist you in preparing grant/contract proposals by providing letters of support, fee structures, project quotations, and descriptions of available technology and resources.  Please contact the specific facility Director or Manager, or send an inquiry to the DHVI Shared Resources Help Desk.

 

“Flow cytometry was performed in the Duke Human Vaccine Institute Research Flow Cytometry Shared Resource Facility (Durham, NC) under the direction of Dr. John F. Whitesides.”

 

“Immune reconstitution monitoring was performed in the Duke Human Vaccine Institute Immune Reconstitution & Biomarker Shared Resource Facility (Durham, NC) under the direction of Dr. Gregory D. Sempowski.”  

“Biomarker profiling was performed in the Duke Human Vaccine Institute Immune Reconstitution & Biomarker Shared Resource Facility (Durham, NC) under the direction of Dr. Gregory D. Sempowski.”

 

“Research was performed in the NIAID Regional Biocontainment Laboratory at Duke (UC6-AI058607) under the direction of Dr. Richard Frothingham.”

 

 

“EIBD animal models were performed in the NIAID Regional Biocontainment Laboratory at Duke (UC6-AI058607, U54-AI057157, P30-AI051445) by the Duke Human Vaccine Institute Infectious Disease Animal Models Shared Resource Facility (Durham, NC) under the direction of Dr. Richard Frothingham.”

 

 

“Aerosol challenges were performed in the NIAID Regional Biocontainment Laboratory at Duke (UC6-AI058607, U54-AI057157, P30-AI051445) by the Duke Human Vaccine Institute Aerobiology Shared Resource Facility (Durham, NC) under the direction of Dr. Richard Frothingham.”

 

 

“IVIS animal imaging was performed in the NIAID Regional Biocontainment Laboratory at Duke (UC6-AI058607, U54-AI057157, P30-AI051445) by the Duke Human Vaccine Institute Immune Biocontainment Animal Imaging Shared Resource Facility (Durham, NC) under the direction of Dr. Gregory D. Sempowski.”

 

 

“Surface plasmon resonance analysis was performed in the Duke Human Vaccine Institute Protein Interaction Shared Resource Facility (Durham, NC) under the direction of Dr. S. Munir Alam.”

“Mass spectrometry and Proteomic analysis were performed in the Duke Human Vaccine Institute Protein Interaction Shared Resource Facility (Durham, NC) under the direction of Dr. S. Munir Alam.”

 

 

“Laser microdissection was performed in the Duke Human Vaccine Institute Laser Capture Microdissection Shared Resource Facility (Durham, NC) under the direction of Dr. S. Munir Alam.”

 

 

“Sequence analysis was performed in the Duke Human Vaccine Institute Viral Genetic Analysis Shared Resource Facility (Durham, NC) under the direction of Dr. Feng Gao.”

 

“CAP and CLIA certified Flow cytometry was performed in the IQA Center Laboratory (Durham, NC) under the direction of Thomas N. Denny.”

 

“Viral load testing was performed in the IQA Center Laboratory (Durham, NC) under the direction of Thomas N. Denny.”

 

Please include all funding affiliations that apply.

 

“This work was supported by a grant from the National Institutes of Health, National Institute of Allergy and Infectious Diseases, Division of AIDS for the Center for HIV/AIDS Vaccine Immunology (CHAVI; U19-AI067854). The sponsor had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.”

 

“This work was made possible by financial support from the National Institutes of Health for the Duke Center for Aids Research (P30-AI064518).”

 

“This work was supported by the Duke Center for Translational Research, which is funded by the National Institutes of Health (P30-AI051445).”

 

“Research was performed in the Regional Biocontainment Laboratory at Duke which received partial support for construction from the National Institutes of Health, National Institute of Allergy and Infectious Diseases (UC6-AI058607).”

 

“This work was supported by the Immune Monitoring Core of the Radiation Countermeasures Center of Research Excellence at Duke, which is funded by the National Institutes of Health (U19-AI067798).”

SERCEB

 

“This work was supported by the Flow, Biomarker and Imaging Core of the Southeastern Regional Center of Excellence for Emerging Infections and Biodefense, which is funded by the National Institutes of Health (U54-AI057157).  Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH.”

“This work was supported by the Aerobiology and Animal Models Core of the Southeastern Regional Center of Excellence for Emerging Infections and Biodefense, which is funded by the National Institutes of Health (U54-AI057157).  Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH.”